Genomic diversity in SS also involves multiple pathways, mainly including the T-cell receptor, NF-kB, JAK/STAT signaling, apoptosis, chromatin remodeling, and DNA damage response [11,37,87]. The gene discussed is NFKB1; the disease is synovial sarcoma.